Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma

4 May 2015

Abstract excerpt

// Stefano Amente 1,2,* , Giorgio Milazzo 3,* , Maria Cristina Sorrentino 1 , Susanna Ambrosio 1 , Giacomo Di Palo 2 , Luigi Lania 2 , Giovanni Perini 3,4 and Barbara Majello 1 1 Department of Biology, University of Naples ‘Federico II’, Naples, Italy 2 Department of Molecular Medicine and Medical Biotechnologies, University of Naples ‘Federico II’, Naples, Italy 3 Department of Pharmacy and Biotechnology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Neuroblastoma Research and Treatments
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26062444
DOI: 10.18632/oncotarget.3990

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastomaPMID 26062444Read ↗

LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 geneSemantic proximity Read ↗

Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for TherapySemantic proximity Read ↗

Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathwaySemantic proximity Read ↗

LSD1, a double-edged sword, confers dynamic chromatin regulation but commonly promotes aberrant cell growthSemantic proximity Read ↗

Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancersSemantic proximity Read ↗

LSD1 inhibition corrects dysregulated MHC-I and dendritic cells activation through IFNγ-CXCL9-CXCR3 axis to promote antitumor immunity in HNSCCSemantic proximity Read ↗

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formationSemantic proximity Read ↗

Advances Toward Lsd1 Inhibitors for Cancer TherapySemantic proximity Read ↗

The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1Semantic proximity Read ↗

Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.Semantic proximity Read ↗

LSD1 Performs Demethylase-Independent and Context-Specific Roles in Ewing SarcomaSemantic proximity Read ↗

LSD1 inhibitors induce neuronal differentiation of Merkel cell carcinoma by disrupting the LSD1-CoREST complex and activating TGFβ signalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.